Candel Therapeutics, Inc. (CADL) Tops Q1 EPS by 50c

Candel Therapeutics, Inc. (NASDAQ: CADL) reported Q1 EPS of $0.13, $0.50 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Candel Therapeutics, Inc. (CADL) click here.

You May Also Be Interested In

• Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
• NAHB housing market index rises to 35 in August from 34
• Stifel on EyePoint Inc. (EYPT): 'we think these data bode well for LUCIA (expected October) barring another unusual asymmetry'